Tirzepatide/BPC, on the other hand, is a combination therapy that includes Tirzepatide, a dual GLP-1 and GIP receptor agonist, and BPC (Body Protective Compound), a peptide that has been shown to have anti-inflammatory and tissue-healing properties
Corticosteroid and NAC nasal douching significantly reduced symptom severity more than two-fold, resolved mucosal edema, and restored mucociliary function in recurrent acute rhinosinusitis patients compared to steroid with ambroxol, leading to better long-term satisfaction (121)
doi: 10.1016/j.hjc.2018.11.008 43 Rico-FontalvoJReinaMSolerMJUnigarro-PalaciosMCastaeda-GonzlezJPQuinteroJJet al
If you have obesity, you're four times more likely to benefit from testosterone replacement than nonobese men
It is not a substitute for medical supervision